AMCR vs OKUR · P/E 18, rev $23.51B vs P/E 72, rev $2.0M
Amcor PLC (AMCR) versus OnKure Therapeutics, Inc. (OKUR) — a side-by-side from cached financials, not a winner call.
Amcor PLC (AMCR) is a packaging & containers company listed on US.
OnKure Therapeutics, Inc. (OKUR) is a biotechnology company listed on US.
Latest reported AMCR revenue for 2026-06-30 was $23.51B. Net income was $1.11B. Revenue was up 362.5% from 2025-06-30 to 2026-06-30. AMCR currently screens at market cap $22.52B and trailing P/E 17.6.
Latest reported OKUR revenue for 2026-06-30 was $2.0M. Net income was -$30.5M. OKUR currently screens at market cap $76.6M and trailing P/E 71.8.
AMCR currently screens at market cap $22.52B and trailing P/E 17.6. OKUR currently screens at market cap $76.6M and trailing P/E 71.8.
Not investment advice. Open the AMCR and OKUR stock pages for the full models.
Not investment advice.